abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

28 Jan 2009

Author:
AFP

Pfizer Drug Trial Case In Nigeria To Restart Feb 25

A Nigerian court Wednesday adjourned to next month the multi-billion-dollar suit against U.S. drug firm Pfizer Inc. (PFE) by the Kano state government to allow for more time for an out-of-court settlement... Kano state is demanding $2.75 billion in compensation from Pfizer for the 1996 trial of a meningitis vaccine, Trovan, on 200 children in Kano. Pfizer and Kano state, which have been engaged in settlement talks since November 2007, are due to report to the court on details of their out-of-court deal... Some 11 children are alleged to have died from the drug test which also caused deformities in 189 others.

Part of the following timelines

Nigeria: Kano lawsuit against Pfizer over drug trial that allegedly harmed children adjourned to allow time for settlement

Pfizer lawsuit (re administration of experimental drug in Nigeria, filed in Nigeria)

Privacy information

This site uses cookies and other web storage technologies. You can set your privacy choices below. Changes will take effect immediately.

For more information on our use of web storage, please refer to our Data Usage and Cookies Policy

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Analytics cookie

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

Your privacy choices for this site

This site uses cookies and other web storage technologies to enhance your experience beyond necessary core functionality.